We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It... Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. Show more
PRINCETON, N.J., March 20, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines...
PRINCETON, N.J., March 01, 2024 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.46 | -4.15537488708 | 11.07 | 11.07 | 10.24 | 2507679 | 10.56939722 | CS |
4 | -1.11 | -9.47098976109 | 11.72 | 11.93 | 10.24 | 2360623 | 11.27295001 | CS |
12 | -2.14 | -16.7843137255 | 12.75 | 14.03 | 10.24 | 3045348 | 12.36893724 | CS |
26 | -0.05 | -0.46904315197 | 10.66 | 14.57 | 9.7 | 3009663 | 12.19412082 | CS |
52 | -1.22 | -10.3127641589 | 11.83 | 14.57 | 9.7 | 2750532 | 12.25521055 | CS |
156 | 0.71 | 7.17171717172 | 9.9 | 14.57 | 5.91 | 2693781 | 10.92785457 | CS |
260 | -2.01 | -15.9270998415 | 12.62 | 25.39 | 5.91 | 2731488 | 11.59957891 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions